Cargando…

Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway

Liver fibrosis is characterized by the activation of hepatic stellate cells (HSCs). Recent findings suggest that senescence of activated HSCs might limit the development of liver fibrosis. Based on previously observed anti-fibrotic effects of soluble egg antigens from Schistosoma japonicum in vitro,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinling, Pan, Jing, Wang, Jianxin, Song, Ke, Zhu, Dandan, Huang, Caiqun, Duan, Yinong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973244/
https://www.ncbi.nlm.nih.gov/pubmed/27489164
http://dx.doi.org/10.1038/srep30957
_version_ 1782446371824992256
author Chen, Jinling
Pan, Jing
Wang, Jianxin
Song, Ke
Zhu, Dandan
Huang, Caiqun
Duan, Yinong
author_facet Chen, Jinling
Pan, Jing
Wang, Jianxin
Song, Ke
Zhu, Dandan
Huang, Caiqun
Duan, Yinong
author_sort Chen, Jinling
collection PubMed
description Liver fibrosis is characterized by the activation of hepatic stellate cells (HSCs). Recent findings suggest that senescence of activated HSCs might limit the development of liver fibrosis. Based on previously observed anti-fibrotic effects of soluble egg antigens from Schistosoma japonicum in vitro, we hypothesized that SEA might play a crucial role in alleviating liver fibrosis through promoting senescence of activated HSCs. We show here that SEA inhibited expression of α-SMA and pro-collagen I and promoted senescence of activated HSCs in vitro. In addition, SEA induced an increased expression of P-p53 and p21. Knockdown of p53 inhibited the expression of p21 and failed to induce senescence of activated-HSCs. Phosphorylated STAT3 was elevated upon SEA stimulation, while loss of STAT3 decreased the level of p53 and senescence of HSCs. Results from immunoprecipitation analysis demonstrated that SOCS3 might be involved in the SEA-induced senescence in HSCs through its interaction with p53. This study demonstrates the potential capacity of SEA in restricting liver fibrosis through promoting senescence in HSCs. Furthermore, a novel STAT3-p53-p21 pathway might participate in the observed SEA-mediated senescence of HSCs. Our results suggest that SEA might carry potential therapeutic effects of restraining liver fibrosis through promoting senescence.
format Online
Article
Text
id pubmed-4973244
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49732442016-08-11 Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway Chen, Jinling Pan, Jing Wang, Jianxin Song, Ke Zhu, Dandan Huang, Caiqun Duan, Yinong Sci Rep Article Liver fibrosis is characterized by the activation of hepatic stellate cells (HSCs). Recent findings suggest that senescence of activated HSCs might limit the development of liver fibrosis. Based on previously observed anti-fibrotic effects of soluble egg antigens from Schistosoma japonicum in vitro, we hypothesized that SEA might play a crucial role in alleviating liver fibrosis through promoting senescence of activated HSCs. We show here that SEA inhibited expression of α-SMA and pro-collagen I and promoted senescence of activated HSCs in vitro. In addition, SEA induced an increased expression of P-p53 and p21. Knockdown of p53 inhibited the expression of p21 and failed to induce senescence of activated-HSCs. Phosphorylated STAT3 was elevated upon SEA stimulation, while loss of STAT3 decreased the level of p53 and senescence of HSCs. Results from immunoprecipitation analysis demonstrated that SOCS3 might be involved in the SEA-induced senescence in HSCs through its interaction with p53. This study demonstrates the potential capacity of SEA in restricting liver fibrosis through promoting senescence in HSCs. Furthermore, a novel STAT3-p53-p21 pathway might participate in the observed SEA-mediated senescence of HSCs. Our results suggest that SEA might carry potential therapeutic effects of restraining liver fibrosis through promoting senescence. Nature Publishing Group 2016-08-04 /pmc/articles/PMC4973244/ /pubmed/27489164 http://dx.doi.org/10.1038/srep30957 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Chen, Jinling
Pan, Jing
Wang, Jianxin
Song, Ke
Zhu, Dandan
Huang, Caiqun
Duan, Yinong
Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
title Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
title_full Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
title_fullStr Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
title_full_unstemmed Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
title_short Soluble egg antigens of Schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the STAT3/p53/p21 pathway
title_sort soluble egg antigens of schistosoma japonicum induce senescence in activated hepatic stellate cells by activation of the stat3/p53/p21 pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973244/
https://www.ncbi.nlm.nih.gov/pubmed/27489164
http://dx.doi.org/10.1038/srep30957
work_keys_str_mv AT chenjinling solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway
AT panjing solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway
AT wangjianxin solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway
AT songke solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway
AT zhudandan solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway
AT huangcaiqun solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway
AT duanyinong solubleeggantigensofschistosomajaponicuminducesenescenceinactivatedhepaticstellatecellsbyactivationofthestat3p53p21pathway